A new drug against Alzheimer’s was approved in the US in January. The news was received with cheers there, because there are no good medicines against it. But this remedy hardly works either. Yet this futile medicine also offers hope: it gives a better insight into where future drugs can intervene.
Presentation: Laura Wismans
Guests: Niki Korteweg & Sander Voormolen
Editing and editing: Elze van Driel
Photo Cavallini James / BSIP
Do you have questions, suggestions or ideas about our journalism? Then email our ombudsman at [email protected].